The PBAC is now seeking public submissions on a new listing process for ‘pan-tumour’ medicines ahead of a special PBAC meeting that will take place in August. Submissions must be made in writing and emailed to the PBAC Secretariat. Further information can be found on the August 2018 PBAC special meeting page. A background paper PD-1 and PD-L1 checkpoint inhibitor immunotherapies: ...
PBAC calls for pan-tumour advice
23 May 2018